Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus

Tingting Zhang, Kaijie Wu, Chen Ding, Kangwei Sun, Zhenfeng Guan, Xinyang Wang, Jer Tsong Hsieh, Dalin He, Jinhai Fan

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Urothelial carcinoma of the bladder (UCB) is the most common malignancy of the urinary tract, nearly half of which contains a mutation in TP53 gene. Hence, therapeutic approach by restoring functional p53 protein in cancer cells will be beneficial. Recent studies have demonstrated the inhibition of cancer cell growth by p53 reactivation using a peptide derived from the p53 C-terminus (p53C). However, the outcome of reactivating p53 in controlling bladder cancer development is limited by its efficiency and specificity of peptide delivery, especially in metastatic animal models. Herein, we report that the cell penetrating peptide (polyarginine, R11)-conjugated p53C can exhibit a preferential uptake and growth inhibit of UCB cells expressing either mutant or wild-type TP53 by the activation of p53-dependent pathway. R11-p53C peptide treatment of preclinical orthotopic and metastatic bladder cancer models significantly decreased the tumor burden and increased the lifespan without a significant cytotoxicity. Based on these results, we believe that R11-p53C peptide has therapeutic potential for primary and metastatic bladder cancer, and R11-mediated transduction may be a useful strategy for the therapeutic delivery of large tumor suppressor molecules to tumor cells in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)37782-37791
Number of pages10
Issue number35
StatePublished - 2015


  • Bladder cancer
  • Cell penetrating peptide
  • Metastatic tumor
  • P53 C-terminus
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus'. Together they form a unique fingerprint.

Cite this